CA
NZ
UK
AU
IND
US
The prior year revenue figure included USD 20.6 million under the original vepdegestrant collaboration with Pfizer and a USD 20.0 million development milestone tied to the Novartis license. The Pfizer revenue did not recur after all remaining deferred revenue was recognized in the second …
The GAAP result reflects a USD 475 million noncash settlement charge recognized when the company completed a pension buy-out of its U.K. defined benefit plan. Net sales rose USD 809 million, with USD 648 million from price and mix, mainly higher aluminum prices, and …
Research and development expense was nearly flat at USD 110.1 million versus USD 109.8 million, but the composition shifted. OtherResearch and Developmentcosts rose USD 15.9 million to USD 16.6 million on milestone activity, employee related costs rose USD 4.6 million as research headcount grew …
Revenue rose 98% to USD 17.7 million from USD 8.9 million, above a consensus estimate of USD 10.78 million. ProductRevenuegrew 78% to USD 5.2 million on USD 4.3 million of ground service equipment deliveries, while service revenue more than doubled to USD 12.5 million …
Gross written premiums rose 10.8% to USD 256.4 million, which was below a consensus revenue estimate of USD 278.64 million. Total revenues were USD 171.8 million, up 19.3% from USD 143.9 million, and net earned premiums grew 17.0% to USD 150.2 million. Chief Executive …
Recurring revenue rose 11% to USD 1,083.1 million, or 11% in constant currency, including 9 points of organic growth, while event-driven revenue dropped 41% to USD 67.4 million asMutual fundproxy revenue fell 74%. Distribution revenue gained 4% to USD 518.2 million, helped by a …
Academic Services revenue fell USD 30.1 million, or 50%, to USD 30.0 million, which the company attributed to reduced traffic and fewer subscribers. Chegg Skilling revenue slipped 6% to USD 16.4 million on lower enrollments in workforce skilling programs sold through its largest third-party …
Academia & Government revenues fell 13.7% to USD 286.9 million, with product group wind-downs outweighing organic growth of 0.9% from new sales and pricing actions. Intellectual Property revenues slipped 1.6% to USD 194.7 million. Segment adjusted EBITDA was USD 134.6 million for Academia & …
The Kito Crosby acquisition, which closed on February 3, 2026, drove the growth, while Legacy CMCO net sales rose 5.3% on pricing and volume. Adjusted EBITDA of USD 111.2 million compared with USD 40.2 million a year earlier, and adjusted grossMarginwas 36.5% versus 35.3%. …
Worldwide attendance increased 17.5% to 63.7 million patrons from 54.2 million. Average ticket price rose 5.0% to USD 8.33 and concession revenue per patron rose 4.7% to USD 6.50. In the U.S., attendance rose 12.7% to 37.4 million on a stronger film slate, with …
Please wait processing your request...